LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 4.36 | 84.90 | 615 | 322 | 1.9066 | 1.7961 | MN20160318_Q02 | C11 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 4.36 | 84.90 | 1 | 322 | 0.0031 | -0.9004 | MN20160318_Q02 | F12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 4.36 | 84.90 | 652 | 322 | 2.0213 | 1.8822 | MN20160318_Q02 | F12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 6.06 | 84.90 | 1 | 365 | 0.0027 | -0.8787 | MN20160318_Q02 | C11 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 6.06 | 84.90 | 713 | 365 | 1.9510 | 1.7470 | MN20160318_Q02 | C11 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 6.06 | 84.90 | 1 | 365 | 0.0027 | -0.8787 | MN20160318_Q02 | F12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 6.06 | 84.90 | 734 | 365 | 2.0085 | 1.7851 | MN20160318_Q02 | F12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 7.77 | 84.90 | 1 | 411 | 0.0024 | -0.8579 | MN20160318_Q02 | C11 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 7.77 | 84.90 | 782 | 411 | 1.9016 | 1.6525 | MN20160318_Q02 | C11 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 7.77 | 84.90 | 1 | 411 | 0.0024 | -0.8579 | MN20160318_Q02 | F12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 7.77 | 84.90 | 811 | 411 | 1.9721 | 1.6953 | MN20160318_Q02 | F12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 9.47 | 84.90 | 2 | 447 | 0.0045 | -0.7905 | MN20160318_Q02 | C11 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 9.47 | 84.90 | 831 | 447 | 1.8573 | 1.5892 | MN20160318_Q02 | C11 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 9.47 | 84.90 | 1 | 447 | 0.0022 | -0.8431 | MN20160318_Q02 | F12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 9.47 | 84.90 | 889 | 447 | 1.9869 | 1.6631 | MN20160318_Q02 | F12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 11.18 | 84.90 | 1 | 492 | 0.0020 | -0.8265 | MN20160318_Q02 | C11 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 11.18 | 84.90 | 900 | 492 | 1.8279 | 1.5371 | MN20160318_Q02 | C11 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 11.18 | 84.90 | 2 | 492 | 0.0041 | -0.7719 | MN20160318_Q02 | F12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 11.18 | 84.90 | 920 | 492 | 1.8686 | 1.5591 | MN20160318_Q02 | F12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 12.88 | 84.90 | 3 | 531 | 0.0056 | -0.7174 | MN20160318_Q02 | C11 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 12.88 | 84.90 | 912 | 531 | 1.7175 | 1.4538 | MN20160318_Q02 | C11 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 12.88 | 84.90 | 1 | 531 | 0.0019 | -0.8135 | MN20160318_Q02 | F12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 12.88 | 84.90 | 992 | 531 | 1.8682 | 1.5331 | MN20160318_Q02 | F12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 14.58 | 84.90 | 62 | 663 | 0.0935 | -0.1005 | MN20160318_Q02 | C11 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 14.58 | 84.90 | 954 | 663 | 1.4380 | 1.2606 | MN20160318_Q02 | C11 |